Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.

Publication Type:

Journal Article

Source:

JAMA : the journal of the American Medical Association, Volume 303, Issue 17, p.1729-37 (2010)

Keywords:

2010, Antineoplastic Agents, Center-Authored Paper, Chemotherapy, Adjuvant, Combined Modality Therapy, Consortium Authored Paper, Humans, Public Health Sciences Division, Randomized Controlled Trials as Topic, Stomach Neoplasms, Survival Analysis, Treatment Outcome

Abstract:

Despite potentially curative resection of stomach cancer, 50% to 90% of patients die of disease relapse. Numerous randomized clinical trials (RCTs) have compared surgery alone with adjuvant chemotherapy, but definitive evidence is lacking.